Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin

Xiaoming Huang, Jiajun Huang, Jingjing Du, Na Zhang, Ze Long, You Yang, Fangfang Zhong, Bowen Zheng, Yunfu Shen, Zhe Huang, Qin Xiang, Junhe Chen, Qianyu Lin, Wanjun Lin, Wenzhe Ma